Clinical trial intelligence platform company, Lokavant, has received an $8 million strategic investment from Mitsui & Co. Ltd. The funding will be used to expand Lokavant's AI-optimized platform across the Asia-Pacific region, with a new APAC headquarters set to open in Tokyo. CMIC Group, Japan's largest contract research organization and one of Lokavant's earliest customers, is a key player in this expansion.